Figure 3.
Diagnostic values for the EV detection assays in CRC samples.
Plasma from healthy control patients (n = 46) and cancer patients (adenoma, n = 51, and CRC, n= 163) was measured with the CD9-CD63 (A) and Epcam-CD63 (B) assays. (C) ROC curves obtained with the CD9-CD63 SiMoa assay, the Epcam-CD63 SiMoa assay and the traditional serological markers CEA and CA125 are shown for colorectal cancer versus healthy controls. The CD9-CD63 assay shows the best AUC (0.96), with a p value at 0.003, when compared with CEA.